114 related articles for article (PubMed ID: 15939501)
1. The use of thiolated polymers as carrier matrix in oral peptide delivery--proof of concept.
Bernkop-Schnürch A; Pinter Y; Guggi D; Kahlbacher H; Schöffmann G; Schuh M; Schmerold I; Del Curto MD; D'Antonio M; Esposito P; Huck C
J Control Release; 2005 Aug; 106(1-2):26-33. PubMed ID: 15939501
[TBL] [Abstract][Full Text] [Related]
2. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
Krauland AH; Guggi D; Bernkop-Schnürch A
J Control Release; 2004 Mar; 95(3):547-55. PubMed ID: 15023465
[TBL] [Abstract][Full Text] [Related]
3. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery.
Krauland AH; Guggi D; Bernkop-Schnürch A
Int J Pharm; 2006 Jan; 307(2):270-7. PubMed ID: 16300914
[TBL] [Abstract][Full Text] [Related]
4. Thiomers for oral delivery of hydrophilic macromolecular drugs.
Bernkop-Schnürch A; Hoffer MH; Kafedjiiski K
Expert Opin Drug Deliv; 2004 Nov; 1(1):87-98. PubMed ID: 16296722
[TBL] [Abstract][Full Text] [Related]
5. In vivo evaluation of an oral drug delivery system for peptides based on S-protected thiolated chitosan.
Dünnhaupt S; Barthelmes J; Iqbal J; Perera G; Thurner CC; Friedl H; Bernkop-Schnürch A
J Control Release; 2012 Jun; 160(3):477-85. PubMed ID: 22542699
[TBL] [Abstract][Full Text] [Related]
6. Thiolated chitosans: useful excipients for oral drug delivery.
Werle M; Bernkop-Schnürch A
J Pharm Pharmacol; 2008 Mar; 60(3):273-81. PubMed ID: 18284806
[TBL] [Abstract][Full Text] [Related]
7. Thiomers: potential excipients for non-invasive peptide delivery systems.
Bernkop-Schnürch A; Krauland AH; Leitner VM; Palmberger T
Eur J Pharm Biopharm; 2004 Sep; 58(2):253-63. PubMed ID: 15296953
[TBL] [Abstract][Full Text] [Related]
8. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system.
Hombach J; Hoyer H; Bernkop-Schnürch A
Eur J Pharm Sci; 2008 Jan; 33(1):1-8. PubMed ID: 17980561
[TBL] [Abstract][Full Text] [Related]
9. Improved synthesis and in vitro characterization of chitosan-thioethylamidine conjugate.
Kafedjiiski K; Hoffer M; Werle M; Bernkop-Schnürch A
Biomaterials; 2006 Jan; 27(1):127-35. PubMed ID: 16045983
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive in vitro and in vivo evaluation of thiolated matrix tablets as a gastroretentive delivery system.
Senyigit ZA; Vetter A; Guneri T; Bernkop-Schnürch A
Drug Deliv; 2011 Aug; 18(6):405-14. PubMed ID: 21463156
[TBL] [Abstract][Full Text] [Related]
11. Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir.
Palmberger TF; Hombach J; Bernkop-Schnürch A
Int J Pharm; 2008 Feb; 348(1-2):54-60. PubMed ID: 17716840
[TBL] [Abstract][Full Text] [Related]
12. In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan.
Föger F; Schmitz T; Bernkop-Schnürch A
Biomaterials; 2006 Aug; 27(23):4250-5. PubMed ID: 16618504
[TBL] [Abstract][Full Text] [Related]
13. In vivo evaluation of an oral salmon calcitonin-delivery system based on a thiolated chitosan carrier matrix.
Guggi D; Kast CE; Bernkop-Schnürch A
Pharm Res; 2003 Dec; 20(12):1989-94. PubMed ID: 14725364
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro evaluation of a novel thiolated chitosan.
Kafedjiiski K; Krauland AH; Hoffer MH; Bernkop-Schnürch A
Biomaterials; 2005 Mar; 26(7):819-26. PubMed ID: 15350788
[TBL] [Abstract][Full Text] [Related]
15. Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system.
Bernkop-Schnürch A; Guggi D; Pinter Y
J Control Release; 2004 Jan; 94(1):177-86. PubMed ID: 14684281
[TBL] [Abstract][Full Text] [Related]
16. Development and in vitro evaluation of a drug delivery system based on chitosan-EDTA BBI conjugate.
Bernkop-Schnürch A; Krauland A; Valenta C
J Drug Target; 1998; 6(3):207-14. PubMed ID: 9888307
[TBL] [Abstract][Full Text] [Related]
17. Development and in vivo evaluation of an oral insulin-PEG delivery system.
Calceti P; Salmaso S; Walker G; Bernkop-Schnürch A
Eur J Pharm Sci; 2004 Jul; 22(4):315-23. PubMed ID: 15196588
[TBL] [Abstract][Full Text] [Related]
18. Thiolated chitosans: design and in vivo evaluation of a mucoadhesive buccal peptide drug delivery system.
Langoth N; Kahlbacher H; Schöffmann G; Schmerold I; Schuh M; Franz S; Kurka P; Bernkop-Schnürch A
Pharm Res; 2006 Mar; 23(3):573-9. PubMed ID: 16411147
[TBL] [Abstract][Full Text] [Related]
19. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Yin L; Ding J; He C; Cui L; Tang C; Yin C
Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
[TBL] [Abstract][Full Text] [Related]
20. pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres.
Quan JS; Jiang HL; Kim EM; Jeong HJ; Choi YJ; Guo DD; Yoo MK; Lee HG; Cho CS
Int J Pharm; 2008 Jul; 359(1-2):205-10. PubMed ID: 18490120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
